We are live on ! Find out more
PCVX icon

Vaxcyte
PCVX

323 hedge funds and large institutions have $11.5B invested in Vaxcyte in 2024 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 139 increasing their positions, 90 reducing their positions, and 62 closing their positions.

New
Increased
Maintained
Reduced
Closed

87% more call options, than puts

Call options by funds: $48.1M | Put options by funds: $25.7M

54% more repeat investments, than reductions

Existing positions increased: 139 | Existing positions reduced: 90

0.88% more ownership

Funds ownership: 112.07% → 112.96% (+0.88%)

0% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 62

2% less funds holding

Funds holding: 328 → 323 (-5)

26% less capital invested

Capital invested by funds: $15.6B → $11.5B (-$4.07B)

48% less funds holding in top 10

Funds holding in top 10: 23 → 12 (-11)

Holders
323
Holders Change
-5
Holders Change %
-1.52%
% of All Funds
4.25%
Holding in Top 10
12
Holding in Top 10 Change
-11
Holding in Top 10 Change %
-47.83%
% of All Funds
0.16%
New
62
Increased
139
Reduced
90
Closed
62
Calls
$48.1M
Puts
$25.7M
Net Calls
+$22.4M
Net Calls Change
-$6.81M

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
+$217M
2
Capital Research Global Investors
Capital Research Global Investors
California
+$130M
3
KCM
Kynam Capital Management
New Jersey
+$129M
4
State Street
State Street
Massachusetts
+$113M
5
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$82.1M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$269M
2
DGM
Darwin Global Management
Jersey
-$251M
3
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$118M
4
FAM
Fred Alger Management
New York
-$71.6M
5
CAM
Cormorant Asset Management
Massachusetts
-$57.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
WWM
301
Wolff Wiese Magana
California
$1.72K – – –
SO
302
Sierra Ocean
California
$1.72K +$2.08K +21 New
Parallax Volatility Advisers
303
Parallax Volatility Advisers
California
$1.64K +$1.99K +20 New
AW
304
Avion Wealth
Texas
$1K – – –
WSFS
305
Wilmington Savings Fund Society
Delaware
$819 -$894 -9 -47%
BIG
306
Brooklyn Investment Group
New York
$819 +$993 +10 New
MAS
307
MPWM Advisory Solutions
Georgia
$819 +$993 +10 New
QCG
308
Quadrant Capital Group
Ohio
$819 +$993 +10 New
WA
309
WPG Advisers
Maryland
$737 +$894 +9 New
CA
310
CoreCap Advisors
Michigan
$655 +$794 +8 New
AF
311
Advisornet Financial
Minnesota
$573 +$695 +7 New
CSWM
312
Cassady Schiller Wealth Management
Ohio
$573 +$695 +7 New
PWA
313
Principia Wealth Advisory
Texas
$491 +$596 +6 New
SPIA
314
Steward Partners Investment Advisory
New York
$491 +$596 +6 New
CFGS
315
Concourse Financial Group Securities
Alabama
$259 – – –
MCM
316
MAI Capital Management
Ohio
$166 +$199 +2 New
TWD
317
True Wealth Design
Ohio
$164 +$199 +2 New
CPG
318
Cornerstone Planning Group
New Jersey
$91 – – –
DPW
319
DiNuzzo Private Wealth
Pennsylvania
$82 +$99 +1 New
GFPC
320
Global Financial Private Client
Florida
$82 +$99 +1 New
JWA
321
JFS Wealth Advisors
Pennsylvania
$82 +$99 +1 New
SS
322
SBI Securities
Japan
$82 +$99 +1 New
DGM
323
Darwin Global Management
Jersey
– -$251M -2,198,187 Closed
O
324
OrbiMed
New York
– -$44.2M -387,000 Closed
EC
325
EcoR1 Capital
California
– -$40.3M -352,464 Closed
11 12
13
14 15

PCVX Hedge Fund Activity: Q4 2024 in Review

323 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Vaxcyte (PCVX) for Q4 2024, worth a combined $11.5B — down 26% from $15.6B a quarter earlier.

Fund positioning in PCVX was balanced in Q4 2024: 62 funds opened new positions, 62 closed out, 139 added to existing stakes and 90 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $217M. The largest seller was Fidelity Investments, cutting an estimated $269M.

  • 323 institutional investors held Vaxcyte (PCVX) as of Q4 2024, down from 328 in Q3 2024.
  • Funds reported $11.5B of Vaxcyte stock for Q4 2024, down 26% quarter-over-quarter.
  • 62 funds opened new Vaxcyte positions in Q4 2024 and 62 closed out, a net change of 0 holders.
  • The largest Vaxcyte buyer in Q4 2024 was Goldman Sachs, an estimated $217M added.
  • The largest Vaxcyte seller in Q4 2024 was Fidelity Investments, an estimated $269M sold.

Based on aggregated 13F filings for Q4 2024.